文献速递关节外科

全膝关节置换术前营养不良普筛具有成本效益:一项马尔可夫分析

Universal Screening for Malnutrition Prior to Total Knee Arthroplasty Is Cost-Effective: A Markov Analysis.
PubMed 文献 · J Arthroplasty · 2022-10-17

本研究采用马尔可夫模型从社会角度评估全膝关节置换术(TKA)前营养不良筛查与干预的成本效益,基础案例分析显示普筛与干预相比不筛查不干预具有成本效益,增量成本效果比为每质量调整生命年(QALY)6,454美元,在筛查成本低于3,373美元、营养干预成本低于12,042美元、营养不良患病率高于2%及营养不良患者假体周围感染(PJI)风险大于1%时仍具成本效益。

要点

  • TKA术前营养不良普筛与干预相比不筛查不干预具有成本效益,ICER为每QALY 6,454美元。
  • 筛查成本低于3,373美元、干预成本低于12,042美元时普筛仍具成本效益。
  • 营养不良患病率高于2%、营养不良患者PJI风险大于1%时普筛仍具成本效益。

核心结论

  • 在临床实践参数下,TKA候选者术前营养不良普筛与干预具有成本效益。
  • 作者认为应考虑营养优化项目以促进营养不良筛查与干预,未来研究应评估其降低PJI风险的效力。

研究设计与样本

  • 研究采用马尔可夫模型预测终身成本与质量调整生命年(QALY),从社会角度确定TKA患者营养不良筛查与干预的成本效益。
  • 成本、健康状态效用和状态转移概率来自已发表文献、本机构医院成本和专家意见。
  • 模型假设30%患者存在营养不良且营养不良干预有效率为50%。
  • 主要结局为增量成本效果比,支付意愿阈值为每QALY 100,000美元,并进行了单因素和双因素敏感性分析。

主要发现

  • 基础案例分析中,普筛与干预相比不筛查不干预具有成本效益,增量成本效果比为每QALY 6,454美元。
  • 只要筛查成本低于3,373美元、营养干预成本低于12,042美元、手术候选者营养不良患病率高于2%、营养不良患者PJI风险大于1%,普筛与干预仍具成本效益。

关键数值与推荐

  • 增量成本效果比为每QALY 6,454美元(基础案例分析,普筛与干预对比不筛查不干预)。
  • 支付意愿阈值为每QALY 100,000美元。
  • 筛查成本低于3,373美元时普筛与干预仍具成本效益。
  • 营养干预成本低于12,042美元时普筛与干预仍具成本效益。
  • 营养不良患病率高于2%时普筛与干预仍具成本效益;营养不良患者PJI风险大于1%时普筛与干预仍具成本效益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing total knee arthroplasty (TKA) who have malnutrition possess an increased risk of periprosthetic joint infection (PJI). Although malnutrition screening and intervention may decrease the risk of PJI, it utilizes healthcare resources. To date, no cost-effectiveness analyses have been performed on the screening and treatment of malnutrition prior to TKA. METHODS: A Markov model projecting lifetime costs and quality-adjusted life years (QALYs) was built to determine the cost-effectiveness of malnutrition screening and intervention for TKA patients from a societal perspective. Costs, health state utilities, and state transition probabilities were obtained from previously published literature, hospital costs at our institution, and expert opinions. Two important assumptions included that 30% of patients would be malnourished and that a malnutrition intervention would be 50% effective. The primary outcome of this study was the incremental cost-effectiveness ratio, with a willingness-to-pay threshold of $100,000 per QALY. One-way and two-way sensitivity analyses were performed to evaluate model parameter assumptions. RESULTS: When using the base case values, universal malnutrition screening and intervention was cost-effective compared to no malnutrition screening or intervention, with an incremental cost-effectiveness ratio of $6,454 per QALY. Universal screening and intervention remained cost-effective, provided the cost of screening remained less than $3,373, the cost of nutritional intervention remained less than $12,042, the prevalence of malnutrition among surgical candidates was higher than 2%, and the risk of PJI among patients with malnutrition was greater than 1%. CONCLUSION: Universal preoperative malnutrition screening and intervention among TKA candidates is cost-effective at parameters encountered in clinical practice. Nutritional optimization programs should be considered to facilitate malnutrition screening and intervention and future studies should evaluate their efficacy at lowering PJI risk.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Torchia MT, Khan IA, Christensen DD, et al. Universal Screening for Malnutrition Prior to Total Knee Arthroplasty Is Cost-Effective: A Markov Analysis. J Arthroplasty. 2022. PMID: 36257507. doi:10.1016/j.arth.2022.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。